Table 1.
Sample | Tbr 1 | Tc 2 | Ld 3 | Pf 4 | Cytotox 5 | SI Tbr |
SI Ld |
SI Pf |
---|---|---|---|---|---|---|---|---|
Pos. contr. | 0.003 ± 0.001 | 0.439 ± 0.094 | 0.127 ± 0.052 | 0.080 ± 0.003 | 0.008 ± 0.001 | |||
(0.008) | (1.688) | (0.312) | (0.250) | (0.019) | ||||
DCM extr. 6 | >10 | 8.83 ± 0.75 | 4.22 ± 1.57 | 3.04 ± 0.07 | 13.4 ± 3.2 | >1.3 | 3.2 | 4.4 |
3 | 2.91 ± 0.21 | 39.9 | 4.77 ± 1.02 | 7.13 ± 0.63 | 16.7 ± 0.1 | 5.7 | 3.5 | 2.3 |
(13.2) | (181) | (21.6) | (32.2) | (75.3) | ||||
4 | 4.03 | 5.02 ± 0.05 | 2.97 ± 0.54 | >5 | 7.88 | 2.0 | 2.7 | >1.6 |
(14.9) | (18.5) | (11.0) | (>18) | (29.1) | ||||
5 | 4.59 ± 0.39 | 16.3 ± 0.3 | 4.04 ± 0.71 | 10.3 ± 1.4 | 28.2 ± 6.9 | 6.2 | 7.0 | 2.7 |
(18.9) | (66.9) | (16.6) | (42.5) | (116) | ||||
6 | 6.37 ± 0.94 | 38.8 ± 2.1 | 5.04 ± 1.17 | 7.19 ± 0.49 | 19.4 ± 1.7 | 3.1 | 3.9 | 2.7 |
(23.7) | (144) | (18.7) | (26.7) | (72.2) | ||||
7 | 2.26 ± 0.18 | 1.88 | 4.19 ± 1.64 | 3.18 ± 0.20 | 0.19 ± 0.05 | 0.1 | <0.1 | <0.1 |
(7.17) | (5.97) | (13.3) | (10.1) | (0.69) | ||||
8 + 9 (1:4) | 1.66 ± 0.12 | 3.90 | 5.31 ± 0.53 | 7.64 ± 2.57 | 2.47 ± 0.36 | 1.5 | 0.5 | 0.3 |
1 T. b. rhodesiense (STIB 900 strain, bloodstream trypomastigotes, positive control: melarsoprol); 2 T. cruzi (Tulahuen C4 strain; intracellular amastigotes, pos. contr.: benznidazole); 3 L. donovani (MHOM-ET-67/L82 strain, axenic amastigotes, pos. contr.: miltefosine); 4 P. falciparum (NF54 IEF, pos.: chloroquine); 5 Cytotoxicity (L6 rat skeletal myoblast cell line, pos.contr.: podophyllotoxin); 6 Data for the crude extract were previously reported and are repeated here for comparison [2].